Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 190

90 Seconds times $20m series B

The Opt and SKY TV NZ-backed video production platform has collected series B financing from investors including Susquehanna International Group.

Feb 26, 2019

Home Depot helps courier $37m to Roadie

Home Depot has taken part in a $37m series C round, which increased the UPS-backed courier service's overall funding to $62m.

Feb 26, 2019

RapidAPI interfaces with Microsoft for $25m

Microsoft’s M12 unit has participated in a $25m funding round for RapidAPI, with existing investor Andreessen Horowitz also returning.

Feb 26, 2019

Circle Media Labs connects to $20m series B

NetGear and T-Mobile have taken part in the connected device technology startup's $20m series B round, investing alongside Third Venture Capital and Relay Ventures.

Feb 25, 2019

Lytics nabs $35m in series C round

Comcast Ventures has taken part in the JMI-led round, which increased the digital marketing platform's overall funding to more than $58m.

Feb 25, 2019

Ctrl-Labs senses GV in $28m funding round

The neural interface-tracking technology developer has increased its overall funding to $67m following a GV-led funding round that included Amazon's Alexa Fund.

Feb 25, 2019

Ajisen Ramen pays another visit to Yunnex

Fast food retailer Ajisen Ramen reinvested in the smart point-of-sale device provider in a $20m series B-plus round led by Hezhi Investment.

Feb 22, 2019

Calypso Biotech dances through series A round

Merck Group and Johnson & Johnson both invested in a $22.6m round for the autoimmune disease drug developer, six years after it was spun off from Merck Serono.

Feb 22, 2019

U-M commits $20m to four spinouts

University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.

Feb 22, 2019

BiomX rides to $32m series B

Johnson & Johnson, Takeda, Chong Kun Dang and Handok were among the participants in a series B round expected to advance acne and IBD drugs into the clinic.

Feb 22, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here